Overview

Adhesion of Lidocaine Topical System 1.8%

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the adhesion performance of ZTlido (lidocaine topical system) 1.8% in normal, healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Scilex Pharmaceuticals, Inc.
Treatments:
Lidocaine